Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Apr 10 2023

Full Issue

Dueling Decisions May Create Patchy Abortion Pill Access And Uncertain Future

Two federal judges issued contradictory rulings Friday over mifepristone, 1 of 2 drugs that has been used for 20 years in the U.S. for a medication abortion. While the Justice Department said it will challenge a Texas court's ruling ordering the FDA to vacate its approval of the drug, the cases are expected to land in the Supreme Court. News outlets explore what the current situation means for patients.

AP: Access To Abortion Pill In Limbo After Competing Rulings

Access to the most commonly used method of abortion in the U.S. plunged into uncertainty Friday following conflicting court rulings over the legality of the abortion medication mifepristone that has been widely available for more than 20 years. For now, the drug the Food and Drug Administration approved in 2000 appeared to remain at least immediately available in the wake of two separate rulings that were issued in quick succession by federal judges in Texas and Washington. (Weber, Perrone and Whitehurst, 4/8)

The 19th: Federal Judges Issue Conflicting Rulings On Medication Abortion Pill Mifepristone

Federal judges have issued contradicting orders about whether mifepristone — one of two drugs used to induce a medication abortion — can be legally distributed. A judge in Texas ruled Friday in a much watched case, saying that the federal government’s approval of the drug must be blocked; his decision, he wrote, takes effect in one week, giving the Department of Justice time to appeal the decision. But another federal judge, in Washington state, found the opposite in a separate case concerning the drug’s approval. That judge, who also ruled Friday, held that a nationwide injunction blocking mifepristone’s distribution would be “inappropriate.” (Luthra, 4/7)

AP: What Does 1870s Comstock Act Have To Do With Abortion Pills? 

A 19th century “anti-vice” law is at the center of a new court ruling that threatens access to the leading abortion drug in the U.S. Dormant for a half-century, the Comstock Act has been revived by anti-abortion groups and conservative states seeking to block the mailing of mifepristone, the pill used in more than half of U.S. abortions. (Perrone, 4/8)

Axios: Ruling Echoes Anti-Abortion Rhetoric

A federal judge's 67-page decision to roll back FDA approval of mifepristone repeatedly borrowed terms from antiabortion advocates, such as "chemical abortion," rather than the generally accepted terms used by the medical community. (Reed, 4/10)

What does that mean for pregnant people right now? —

The Washington Post: Can I Still Get A Medication Abortion?

Access to the two-drug regimen will likely vary across the country. In states where abortion is legal, clinics could limit their offerings to surgical abortions, which require far more time and resources than pills. But many providers say they will continue to offer medication abortions — using only misoprostol if need be. Others say they have been stockpiling mifepristone while it is still FDA-approved, and will continue using that supply of the drug. (Kitchener, Marimow, McGinley, Roubein and Sellers, 4/7)

San Francisco Chronicle: Medication Abortions Will Be More Painful Without Mifepristone

By suspending a drug used in medicated abortions Friday, a conservative federal judge in Texas did more than make it harder for people to obtain abortions. U.S. District Judge Matthew Kacsmaryk also made it more painful. And that may be the point, abortion rights advocates say. (Garofoli, 4/7)

PBS NewsHour: Analysis: 4 Questions Answered About The Courts And The Abortion Pill Mifepristone

Dueling, back-to-back rulings by federal judges about access to the drug mifepristone, which is used in most abortions in the United States, have raised questions about the future of reproductive health care in the country. (Serino, 4/9)

KHN: Journalists Explain Impact Of Texas Judge’s ACA Decision And Cuts In Federal Food Benefits 

KHN chief Washington correspondent Julie Rovner discussed the aftermath of a federal judge’s decision in Texas that blocks the Affordable Care Act’s provision on preventive care benefits on Slate’s “What Next” on April 5. (4/8)

The history behind the rulings —

The Washington Post: Texas Judge Delivers On The Hopes Of His Antiabortion World 

When Judge Matthew Kacsmaryk was a young father, his wife captured much of their daily life on a parenting blog that highlighted the family’s strong antiabortion beliefs. One photo showed one of their children, a toddler, in a T-shirt that read “I survived Roe v. Wade.” “As you might guess, Matt LOVES this shirt,” Kacsmaryk’s wife wrote in January 2009, referring to her husband. “I put it on her today not even realizing that today is the anniversary of Roe v. Wade.” (Kitchener, 4/8)

CNN: Meet The Judge Who Ruled Medication Abortion Must Remain Available In Some States

US District Judge Thomas Owen Rice of the Eastern District of Washington, an appointee of former President Barack Obama, ordered the federal government to keep the drug available in 17 states plus the District of Columbia. ... here’s what you need to know about Rice. (Kashiwagi, 4/8)

The Washington Post: The Abortion Pill’s 1992 Supreme Court Battle And The Woman Who Started It

The plane from London had landed at New York’s John F. Kennedy International Airport, and Leona Benten was weeping on the tarmac when U.S. customs officials seized the abortion pills she wanted to use to end her pregnancy, which were banned in America. Benten, a social worker and activist from Berkeley, Calif., was 6½ weeks pregnant and 29 years old when she volunteered in the summer of 1992 to be the test case in the legal fight challenging the Food and Drug Administration’s ban on importing RU-486, the French-made abortion pill that later became known as mifepristone. Lawrence Lader, an influential abortion rights leader who organized the trip for Benten, had notified U.S. customs officials in advance of what was happening. Then, federal officials confronted her and confiscated her pills on July 1, 1992. (Bella, 4/8)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 22
  • Thursday, May 21
  • Wednesday, May 20
  • Tuesday, May 19
  • Monday, May 18
  • Friday, May 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF